HUMANISIERTE ODER CHIMÄRE CD3-ANTIKÖRPER

European patent · EP4249515 · In force

Register entry

Publication number
EP4249515
Application number
EP23174159
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 8, 2015
Published
Sep 27, 2023
Granted
Jun 18, 2025
Protection ends at the latest
Jan 7, 2035
Next annual fee due
Jan 31, 2027
IPC classes
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/06 (2006.01)
C07K 16/10 (2006.01)
C07K 16/28 (2006.01)
C07K 16/32 (2006.01)
Priority
DK PA201400009 09.01.2014
WO PCT/EP2014/050340 09.01.2014
WO PCT/EP2014/064326 04.07.2014
Divided from
EP15700081
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 30, 2026

    Change

    Published in Swissreg on 30.04.2026

  2. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  3. Aug 21, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.08.2025

  4. Jun 18, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.06.2025

Parties

Inventor

BRINK, Edward Norbert Van Den

NL-3584 Utrecht, NL

NEIJSSEN, Joost J.

NL-3584 Utrecht, NL

LABRIJN, Aran Frank

NL-3584 Utrecht, NL

MEESTERS, Joyce

NL-3584 Utrecht, NL

SCHUURMAN, Janine

NL-3584 Utrecht, NL

ALTINTAS, Isil

NL-3584 Utrecht, NL

PARREN, Paul

NL-3584 Utrecht, NL

RADEMAKER, Rik

NL-3584 Utrecht, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.